Endo ERN
Find an expert
Endo ERN
Search
  • Rare Endocrine Conditions

    Endocrine Conditions

    Endo-ERN is focused on 8 main thematic groups (MTGs) which cover rare and/or complex endocrine conditions

    Go to overview

    Categories

    • MTG1Adrenal
    • MTG2Disorders of Calcium & Phosphate Homeostasis
    • MTG3Genetic Disorders of Glucose & Insulin Homeostasis
    • MTG4Genetic Endocrine Tumour Syndromes
    • MTG5Growth & Genetic Obesity Syndromes
    • MTG6Hypothalamic and Pituitary Conditions
    • MTG7Sex Development & Maturation
    • MTG8Thyroid
  • About Us

    About Us

    Endo-ERN is a network of 100+ Reference Centres (RCs) in 27 EU member states+Norway that offers access to clinical experts for patients with rare endocrine conditions.  

    Go to overview

    Who we are

    • About Endo-ERN
    • What we do
    • Reference centres
    • Work packages
    • Project team

    Information

    • Events
    • FAQ
    • Newsletter
    • Contact
    • ERNs
  • For Professionals

    For Professionals

    Endo-ERN is the network for rare endocrine conditions providing healthcare professionals with access to a variety of resources to support patient care.  

    Our Network

    • About Endo-ERN
    • Find a Reference Centre

    Research

    • Registries
    • Publications
    • Clinical Trials

    Support Tools

    • Virtual Consultations
    • Guidelines
    • COVID-19

    Training & Education

    • Webinars
    • Exchange Programme
  • For Members

    For Members

    If you work at a member institution this page will help with your Endo-ERN contributions.  

    Go to overview

    Quick Links

    • Cite Endo-ERN
    • CPMS 2.0
    • GA2026
    • The Journal

    Evaluation

    • Continuous Monitoring Exercise
    • 5-year evaluation
    • HCP Performance System

    Network Participation

    • Event Endorsement
    • Member Survey
    • Webinar Planning
    • MTG Representatives

    Membership Management

    • Update Member Contacts
    • Request Disease Area Expansion
    • Termination Policy
  • For Patients

    For Patients

    Access to rare disease expertise without the need to travel is a core ERN objective.  Our ePAGs contribute to all Endo-ERN activities.  

    Go to overview

    Patient information

    • What are European Reference Networks?
    • Cross-border healthcare
    • Rare endocrine conditions
    • Patient materials

    ePAG information

    • European Patient Advocacy Groups
    • Patient representatives
    • How to become an Endo-ERN ePAG
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
  • Rare Endocrine Conditions
  • About Us
  • For Professionals
  • For Members
  • For Patients
  • Search
Endo ERN
Find an expert
Search
/ Publications Overview / Publications Database

Endo-ERN Publications Database

RDD IssuesBack to Publications Overview

Filter list of publications

890 publication(s) found matching the search criteria

Clinical course of autoimmune thyroid diseases in women with prolactinomas: Results from a prospective study in a single tertiary centre


Author(s): Elenkova A, Racheva P, Kirilov G, Zacharieva S
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: Prolactinoma
Publication: Endocrinología, Diabetes y Nutrición (English ed.) v70 p27-34 Year: 2023 ORPHAcode / other: ORPHA2965
DOI: 10.1016/j.endien.2023.05.008 Keywords: Autoimmune thyroiditis,Hipertiroidismo,Hipotiroidismo,Hyperthyroidism,Hypothyroidism,Prolactin,Prolactina,Prolactinoma,Tiroiditis autoinmune
MTG6

Who is sensitising whom? A participatory interview guide development as an awareness tool within a health care research project


Author(s): Kalender U, Wiegmann S, Ernst M, Ihme L, Neumann U, Stöckigt B
Affiliated Institution / ERN: Charité Universitätsmedizin Berlin ;
Condition / Disease:
Publication: Heliyon v9.6 pe16778 Year: 2023 ORPHAcode / other:
DOI: 10.1016/j.heliyon.2023.e16778 Keywords:

Proposal of early CT morphological criteria for response of liver metastases to systemic treatments in gastroenteropancreatic neuroendocrine tumors: Alternatives to RECIST


Author(s): de Mestier L, Resche‐Rigon M, Dromain C, Lamarca A, La Salvia A, de Baker L, Fehrenbach U, Pusceddu S, Colao A, Borbath I, de Haas R, Rinzivillo M, Zerbi A, Funicelli L, de Herder WW, Selberherr A, Wagner AD, Manoharan P, De Cima A, Lybaert W, Jann H, Prinzi N, Faggiano A, Annet L, Walenkamp A, Panzuto F, Pedicini V, Pitoni MG, Siebenhuener A, Mayerhoefer ME, Ruszniewski P, Vullierme M
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: neuroendocrine tumors
Publication: Journal of Neuroendocrinology v35.6 Year: 2023 ORPHAcode / other: ORPHA100092
DOI: 10.1111/jne.13311 Keywords: computed tomography,neuroendocrine tumors,response evaluation,systemic treatments
MTG4

The pathogenic p.Gln319Ter variant is not causing congenital adrenal hyperplasia when inherited in one of the duplicated CYP21A2 genes


Author(s): Fanis P, Skordis N, Toumba M, Picolos M, Tanteles GA, Neocleous V, Phylactou LA
Affiliated Institution / ERN: Cyprus Institute of Neurology and Genetics ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.3389/fendo.2023.1156616 Keywords: 21-hyrdroxylase deficiency,CAH,CYP21A2,RCCX,gene duplications
MTG1

Prolyl Endopeptidase-like Deficiency Associated with Growth Hormone Deficiency


Author(s): Sayol-Torres L, Valenzuela MI, Tomasini R, Fernández-Alvarez P, Clemente M, Yeste D
Affiliated Institution / ERN: Hospital Universitari Vall d’Hebron ;
Condition / Disease: Non-acquired pituitary hormone deficiency
Publication: Journal of Clinical Research in Pediatric Endocrinology v15.2 p205-209 Year: 2023 ORPHAcode / other: ORPHA95488
DOI: 10.4274/jcrpe.galenos.2021.2021.0128 Keywords: Prolyl endopeptidase-like,genetics,growth hormone deficiency
MTG6

Plasma-free metanephrines, nerve growth factor, and renalase significance in patients with PCOS


Author(s): Robeva R, Elenkova A, Kirilov G, Zacharieva S
Affiliated Institution / ERN: USHATE “ACAD IVAN Penchev” ;
Condition / Disease: PCOS
Publication: Endocrine v81.3 p602-612 Year: 2023 ORPHAcode / other:
DOI: 10.1007/s12020-023-03404-9 Keywords: Nerve growth factor (NGF),Normetanephrine,Polycystic ovarian syndrome (PCOS),Renalase,Sympathetic noradrenergic activity
MTG7

Current Treatments for Patients with Genetic Obesity


Author(s): Faccioli N, Poitou C, Clément K, Dubern B
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Genetic non-syndromic obesity, leptin/melanocortin pathway
Publication: Journal of Clinical Research in Pediatric Endocrinology v15.2 p108-119 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.4274/jcrpe.galenos.2023.2023-3-2 Keywords: Genetic obesity,syndromic obesity,personalized medicine,setmelanotide
MTG5

What is the role of CHCHD2 in adrenal tumourigenesis?


Author(s): Karapanagioti A, Nasiri-Ansari N, Moustogiannis A, Trigas GC, Zografos G, Aggeli C, Kyriakopoulos G, Choreftaki T, Philippou A, Kaltsas G, Kassi E, Angelousi A
Affiliated Institution / ERN: General Hospital of Athens “LAIKO” ;
Condition / Disease: Adrenocortical carcinoma
Publication: Endocrine v81.2 p357-367 Year: 2023 ORPHAcode / other: ORPHA1501
DOI: 10.1007/s12020-023-03393-9 Keywords: Adrenal adenomas,Adrenocortical carcinoma,Apoptosis,BAX,BCL2,CHCHD2
MTG1

Quality of life in children and adolescents with growth hormone deficiency and their caregivers: an Italian survey


Author(s): Maghnie M, Orso M, Polistena B, Cappa M, Pozzobon G, d’Angela D, Patti G, Spandonaro F, Granato S, Di Virgilio R, La Torre D, Salerno M
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: growth hormone deficiency
Publication: Journal of Endocrinological Investigation v46.12 p2513-2523 Year: 2023 ORPHAcode / other: ORPHA631; ORPHA101957;
DOI: 10.1007/s40618-023-02106-3 Keywords: Children,Growth hormone deficiency,Italy,Quality of life,Survey
MTG7

Child and adolescent obesity


Author(s): Lister NB, Baur LA, Felix JF, Hill AJ, Marcus C, Reinehr T, Summerbell C, Wabitsch M
Affiliated Institution / ERN: Ulm University Medical Center ;
Condition / Disease: Child and adolescent obesity
Publication: Nature Reviews Disease Primers v9.1 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.1038/s41572-023-00435-4 Keywords:
MTG5

Novel Insulin-Like Growth Factor 1 Gene Mutation: Broadening of the Phenotype and Implications for Insulin Resistance


Author(s): Giacomozzi C, Martin A, Fernández MC, Gutiérrez M, Iascone M, Domené HM, Dominici FP, Bergadá I, Cangiano B, Persani L, Pennisi PA
Affiliated Institution / ERN: AOU-Bologna ;
Condition / Disease: growth hormone deficiency (GHD)
Publication: The Journal of Clinical Endocrinology & Metabolism v108.6 p1355-1369 Year: 2023 ORPHAcode / other: ORPHA101957; ORPHA95488
DOI: 10.1210/clinem/dgac738 Keywords: IGF1 mutation,IGF1 primary insufficiency,impaired glucose tolerance,insulin resistance,short stature
MTG5 MTG6

Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing’s syndrome: results from a retrospective multicenter study


Author(s): Detomas M, Ritzel K, Nasi-Kordhishti I, Schernthaner-Reiter MH, Losa M, Tröger V, Altieri B, Kroiss M, Kickuth R, Fassnacht M, Micko A, Honegger J, Reincke M, Deutschbein T
Affiliated Institution / ERN: University Hospital Würzburg ;
Condition / Disease: Cushing Syndrome
Publication: European Journal of Endocrinology v188.5 p448-456 Year: 2023 ORPHAcode / other: ORPHA647758; ORPHA189427; ORPHA314749;
DOI: 10.1093/ejendo/lvad050 Keywords: Catheter,Cushing’s disease,IPSS,ectopic,petrosal sinus,pituitary,prolactin
MTG1

Individuals with numerical and structural variations of sex chromosomes: interdisciplinary management with focus on fertility potential


Author(s): Juul A, Gravholt CH, De Vos M, Koledova E, Cools M
Affiliated Institution / ERN: Aarhus University Hospital ;
Condition / Disease: DSD
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA325546
DOI: 10.3389/fendo.2023.1160884 Keywords: DSD,Klinefelter syndrome,NSVSC,Turner syndrome,sex chromosomes
MTG7

Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes


Author(s): Heller S, Battelino T, Bailey TS, Pieber TR, Hövelmann U, Plum‐Mörschel L, Melgaard AE, Aronson R, DiMeglio LA, Johansen T, Danne T
Affiliated Institution / ERN: University Medical Centre Ljubljana ;
Condition / Disease: Diabetes mellitus
Publication: Diabetes, Obesity and Metabolism v25.5 p1351-1360 Year: 2023 ORPHAcode / other:
DOI: 10.1111/dom.14987 Keywords: glucagon,glycaemic control,hypoglycaemia,type 1 diabetes
MTG3

Characterization of lymphocyte profiles in children with syndromic obesity


Author(s): Dieme A, André S, Lapillonne H, Tounian P, Clément K, Dubern B
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: Syndromic Genetic Obesity
Publication: Archives de Pédiatrie v30.4 p212-218 Year: 2023 ORPHAcode / other: ORPHA240371
DOI: 10.1016/j.arcped.2023.02.009 Keywords: Adipose tissue,Childhood obesity,Immunology,Inflammation
MTG5

Immune checkpoint inhibitor-related thyroid dysfunction


Author(s): Illouz F, Briet C, Rodien P
Affiliated Institution / ERN: CHU d'Angers ;
Condition / Disease: Immune checkpoint inhibitor-related thyroid dysfunction
Publication: Annales d'Endocrinologie v84.3 p346-350 Year: 2023 ORPHAcode / other:
DOI: 10.1016/j.ando.2023.03.005 Keywords: Dysfonction thyroïdienne,Hypothyroidism,Hypothyroïdie,Immune checkpoint inhibitors,Inhibiteurs des points de contrôle immunitaire,Thyroid dysfunction,Thyroiditis,Thyrotoxicose,Thyrotoxicosis,Thyroïdite
MTG8

Novel therapeutics in rare genetic obesities: A narrative review


Author(s): Dubern B, Faccioli N, Poitou C, Clément K
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: obesity associated with defect in leptin/melanocortin pathway
Publication: Pharmacological Research v191 p106763 Year: 2023 ORPHAcode / other: ORPHA77828
DOI: 10.1016/j.phrs.2023.106763 Keywords: Childhood obesity,Genetics,Hypothalamus,Melanocortins,Monogenic obesity
MTG5

Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population-based study


Author(s): Berglund A, Ornstrup MJ, Lind-Holst M, Dunø M, Bækvad-Hansen M, Juul A, Borch L, Jørgensen N, Rasmussen ÃK, Andersen M, Main KM, Hansen D, Gravholt CH
Affiliated Institution / ERN: Aarhus University Hospital ;
Condition / Disease: Congenital Adrenal Hyperplasia
Publication: The Lancet Regional Health - Europe v28 p100598 Year: 2023 ORPHAcode / other: ORPHA418
DOI: 10.1016/j.lanepe.2023.100598 Keywords: Congenital adrenal hyperplasia,Diagnosis age,Epidemiology,Incidence,Prevalence
MTG1

Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants


Author(s): Taïeb D, Wanna GB, Ahmad M, Lussey-Lepoutre C, Perrier ND, Nölting S, Amar L, Timmers HJLM, Schwam ZG, Estrera AL, Lim M, Pollom EL, Vitzthum L, Bourdeau I, Casey RT, Castinetti F, Clifton-Bligh R, Corssmit EPM, de Krijger RR, Del Rivero J, Eisenhofer G, Ghayee HK, Gimenez-Roqueplo A, Grossman A, Imperiale A, Jansen JC, Jha A, Kerstens MN, Kunst HPM, Liu JK, Maher ER, Marchioni D, Mercado-Asis LB, Mete O, Naruse M, Nilubol N, Pandit-Taskar N, Sebag F, Tanabe A, Widimsky J, Meuter L, Lenders JWM, Pacak K
Affiliated Institution / ERN: University Medical Center Groningen ;
Condition / Disease: Phaeochromocytoma and paraganglioma
Publication: The Lancet Diabetes & Endocrinology v11.5 p345-361 Year: 2023 ORPHAcode / other: ORPHA276621
DOI: 10.1016/s2213-8587(23)00038-4 Keywords:
MTG1

João Raposo: moving beyond recommendations and guidelines


Author(s): Burki T
Affiliated Institution / ERN: APDP – Diabetes Portugal ;
Condition / Disease: diabetes and behaviour
Publication: The Lancet Diabetes & Endocrinology v11.5 p313 Year: 2023 ORPHAcode / other:
DOI: 10.1016/s2213-8587(23)00095-5 Keywords:

Adipose tissue function and insulin sensitivity in syndromic obesity of Bardet-Biedl syndrome


Author(s): Baig S, Wanninayake S, Foggensteiner L, Elhassan YS, Manolopoulos K, Ali S, Lassen PB, Clément K, Steeds RP, Tomlinson JW, Geberhiwot T
Affiliated Institution / ERN: Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpétrière ;
Condition / Disease: BBS
Publication: International Journal of Obesity v47.5 p382-390 Year: 2023 ORPHAcode / other: ORPHA110
DOI: 10.1038/s41366-023-01280-x Keywords:
MTG5

Transition for adolescents with a rare disease: results of a nationwide German project


Author(s): Grasemann C, Höppner J, Burgard P, Schündeln MM, Matar N, Müller G, Krude H, Berner R, Lee-Kirsch MA, Hauck F, Wainwright K, Baumgarten S, Atinga J, Bauer JJ, Manka E, Körholz J, Kiewert C, Heinen A, Kretschmer T, Kurth T, Mittnacht J, Schramm C, Klein C, Graessner H, Hiort O, Muntau AC, Grüters A, Hoffmann GF, Choukair D
Affiliated Institution / ERN: Charité Universitätsmedizin Berlin ;
Condition / Disease: transition of care, rare diseases
Publication: Orphanet Journal of Rare Diseases v18.1 Year: 2023 ORPHAcode / other:
DOI: 10.1186/s13023-023-02698-2 Keywords: Adolescent health,Empowerment,Health literacy,Pathway,Rare disease,Transition
MTG1 MTG2 MTG3 MTG4 MTG5 MTG6 MTG7 MTG8

Increase of jump performance during GH treatment in short children born SGA


Author(s): Schweizer R, Martin DD, Binder G
Affiliated Institution / ERN: Universitätsklinikum Tübingen ;
Condition / Disease: growth hormone deficiency (GHD)
Publication: Frontiers in Endocrinology v14 Year: 2023 ORPHAcode / other: ORPHA631; ORPHA101957
DOI: 10.3389/fendo.2023.1122287 Keywords: children,growth hormone treatment (GH),jumping mechanography,muscle function,muscle power,peak jump force,small for gestation age (SGA)
MTG5 MTG6

Unusual causes of hyperthyrotropinemia and differential diagnosis of primary hypothyroidism: a revised diagnostic flowchart


Author(s): Campi I, Dell’Acqua M, Stellaria Grassi E, Cristina Vigone M, Persani L
Affiliated Institution / ERN: San Raffaele hospital - Milan ;
Condition / Disease: Resistance to thyroid hormone
Publication: European Thyroid Journal v12.4 Year: 2023 ORPHAcode / other: ORPHA596426
DOI: 10.1530/etj-23-0012 Keywords: TSH,assay artifacts,consumptive hypothyroidism,deiodinases,hypothyroidism,macro-TSH,malabsorption,resistance to TSH
MTG8

Cushing’s syndrome in the elderly: data from the European Registry on Cushing’s syndrome


Author(s): Amodru V, Ferriere A, Tabarin A, Castinetti F, Tsagarakis S, Toth M, Feelders RA, Webb SM, Reincke M, Netea-Maier R, Kastelan D, Elenkova A, Maiter D, Ragnarsson O, Santos A, Valassi E, Amaral C, Ambrogio A, Aranda G, Arosio M, Balomenaki M, Berr-Kirmair C, Bertherat J, Bolanowski M, Bollerslev J, Cardoso H, Carvalho D, Cavagnini F, Ceccato P, Chabre O, Chanson P, Christ E, Demtröder Zentrum fur Endokrinologie F, Denes J, Deutschbein T, Dimopoulou C, Dreval A, Droste M, Duarte JS, Dusek T, Ertürk E, Evang JA, Fajardo C, Fazel J, Feelders RA, Fica S, García-Centeno R, Ghigo E, Goth M, Godlewska M, Greenman Y, Halperin I, Hanzu FA, Hermus A, Johannsson G, Hubina E, Januszewska A, Kamenicky P, Kasperlik-Zaluska A, Kirchner J, Kastelan D, Komerdus I, Kraljevic I, Krsek M, Kruszynska A, Lamas C, Lambrescu I, Lang S, Luger A, Maiter D, Marpole N, Martin S, Martinie M, Martins Oliveira MJ, Moros O, Netea-Maier R, Newell-Price J, Orbetzova M, Paiva I, Pecori Giraldi F, Percovich JC, Pereira AM, Pfeifer M, Pickel J, Pirags V, Ragnarsson O, Reghina AD, Reincke M, Riesgo P, Roberts M, Roerink S, Roig O, Rowan C, Rudenko P, Salvador J, Santos A, Scaroni C, Sigurjonsdottir HA, Skoric Polovina T, Smith R, Stachowska B, Stalla G, Strasburger C, Tabarin A, Terzolo M, Tőke J, Tóth M, Touraine P, Trainer PJ, Tsagarakis S, Valassi E, Vila G, Vinay S, Wagenmakers M, Werner S, Young J, Zdunowski P, Zopf K, Zopp S, Zosin I
Affiliated Institution / ERN: University Hospitals Saint-Luc ; Semmelweis University ; Hospital de la Santa Creu i Sant Pau ; Evangelismos General Hospital ;
Condition / Disease: Cushing's syndrome
Publication: European Journal of Endocrinology v188.4 p395-406 Year: 2023 ORPHAcode / other: ORPHA96253; ORPHA647758; ORPHA189427; ORPHA314749;
DOI: 10.1093/ejendo/lvad008 Keywords: Cushing's syndrome,ERCUSYN,aging,elderly patients
MTG1 MTG6

Skin manifestations in rare types of diabetes and other endocrine conditions


Author(s): Reschke F, Biester T, von dem Berge T, Jamiolkowski D, Hasse L, Dassie F, Maffei P, Klee K, Kordonouri O, Ott H, Danne T
Affiliated Institution / ERN: Hannoversche Kinderheilanstalt ;
Condition / Disease: rare diabetes
Publication: Endocrine Connections v12.7 Year: 2023 ORPHAcode / other: ORPHA101952
DOI: 10.1530/ec-22-0410 Keywords: cutaneous effects of rare diabetes,rare dermatologic changes in endocrine disorders,rare endocrinopathies,rare types of diabetes
MTG3

Arginine‐stimulated copeptin in children and adolescents


Author(s): Binder G, Weber K, Peter A, Schweizer R
Affiliated Institution / ERN: Universitätsklinikum Tübingen ;
Condition / Disease: AVP deficiency
Publication: Clinical Endocrinology v98.4 p548-553 Year: 2023 ORPHAcode / other: ORPHA101957; ORPHA30925;
DOI: 10.1111/cen.14880 Keywords: arginine,central diabetes insipidus,copeptin,polydipsia,polyuria,short stature
MTG7

Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome


Author(s): Leiding JW, Vogel TP, Santarlas VG, Mhaskar R, Smith MR, Carisey A, Vargas-Hernández A, Silva-Carmona M, Heeg M, Rensing-Ehl A, Neven B, Hadjadj J, Hambleton S, Ronan Leahy T, Meesilpavikai K, Cunningham-Rundles C, Dutmer CM, Sharapova SO, Taskinen M, Chua I, Hague R, Klemann C, Kostyuchenko L, Morio T, Thatayatikom A, Ozen A, Scherbina A, Bauer CS, Flanagan SE, Gambineri E, Giovannini-Chami L, Heimall J, Sullivan KE, Allenspach E, Romberg N, Deane SG, Prince BT, Rose MJ, Bohnsack J, Mousallem T, Jesudas R, Santos Vilela MMD, O’Sullivan M, Pachlopnik Schmid J, Průhová Å, Klocperk A, Rees M, Su H, Bahna S, Baris S, Bartnikas LM, Chang Berger A, Briggs TA, Brothers S, Bundy V, Chan AY, Chandrakasan S, Christiansen M, Cole T, Cook MC, Desai MM, Fischer U, Fulcher DA, Gallo S, Gauthier A, Gennery AR, Gonçalo Marques J, Gottrand F, Grimbacher B, Grunebaum E, Haapaniemi E, Hämäläinen S, Heiskanen K, Heiskanen-Kosma T, Hoffman HM, Gonzalez-Granado LI, Guerrerio AL, Kainulainen L, Kumar A, Lawrence MG, Levin C, Martelius T, Neth O, Olbrich P, Palma A, Patel NC, Pozos T, Preece K, Lugo Reyes SO, Russell MA, Schejter Y, Seroogy C, Sinclair J, Skevofilax E, Suan D, Suez D, Szabolcs P, Velasco H, Warnatz K, Walkovich K, Worth A, Aleshkevich S, Allende LM, Atkinson TP, Atschekzei F, Aydemir S, Aygunes U, Barlogis V, Baumann U, Belko J, Bezrodnik L, Biebl A, Broderick L, Bunin NJ, Caldirola MS, Castelle M, Celmeli F, Charbonnier L, Chatila TA, Chellapandian D, Cokugras H, Conlon N, Cox F, Crickx E, Dalgic B, ASH Dalm V, Danielian S, Dominguez-Pinilla N, Dujovny T, Ebbo M, Eken A, Esty B, Fabre A, Fischer A, Hannibal M, Huppert L, Ikeda MD, Jolles S, Jolly KW, Jones N, Kanariou M, Karakoc-Aydiner E, Karamantziani T, Kelaidi C, Keogan M, Pac Kisaarslan A, Kiykim A, Klocperk A, Kotsonis K, Kuzmenko N, Leroy S, Lianou D, Longhurst H, Lorenz MR, Maffucci P, Manson A, Marchal S, Malphettes M, Marega LF, Mauracher AA, Meesilpavikai K, Miller H, Mombourquette J, Morgan NG, Mukhina A, Nathalie A, Nelken B, Nolan D, Norlin A, Oleastro M, Ozcan A, Pasquet M, Pegler JR, Picard C, Polychronopoulou S, Quartier P, Quesada JF, Ramakers J, Randall KL, Rao VK, Remiker A, Resin G, Richmond P, Rieux-Laucat F, Rodina Y, Rohrlich P, Sachs J, Sakovich I, Santarlas C, Sari S, Sawicki G, Schauer U, Scheffler Mendoza SC, Schvetz O, Schmidt RE, Schwarz K, Sediva A, Sinclair K, Slatter M, Sleasman J, Stergiou K, Suratannon N, Tanita K, Thompson G, Travis S, Trojan T, Tsinti M, Unal E, Urdinez L, Vazquez-Gomez F, Villa M, Weinrich M, Weiss MJ, Wright B, Yilmaz E, Zachova R, Zhang Y, Seppänen MR, Torgerson TR, Sogkas G, Ehl S, Tangye SG, Cooper MA, Milner JD, Forbes Satter LR
Affiliated Institution / ERN: University Hospital Motol ; AOU-Bologna ;
Condition / Disease: monogenic autoimmunity
Publication: Journal of Allergy and Clinical Immunology v151.4 p1081-1095 Year: 2023 ORPHAcode / other: ORPHA438159
DOI: 10.1016/j.jaci.2022.09.002 Keywords: STAT3,autoimmunity,cytopenia,gain of function,immune dysregulation,immunodeficiency,lymphoproliferation,precision medicine

The impact of different calibration matrices on the determination of insulin-like growth factor 1 by high-resolution-LC-MS in acromegalic and growth hormone deficient patients


Author(s): Simstich S, Züllig T, D'Aurizio F, Biasotto A, Colao A, Isidori AM, Lenzi A, Fauler G, Köfeler HC, Curcio F, Herrmann M
Affiliated Institution / ERN: AOU Federico II - Naples ;
Condition / Disease: acromegaly and GH deficiency
Publication: Clinical Biochemistry v114 p95-102 Year: 2023 ORPHAcode / other: ORPHA963
DOI: 10.1016/j.clinbiochem.2023.02.008 Keywords: Hormone,Insulin-like Growth Factor 1 (IGF-1),Liquid Chromatography High-Resolution Mass Spectrometry (LC-HRMS),Online Solid Phase Extraction (OSPE),Peptide,Quantification,Serum
MTG6

Rare forms of genetic paediatric adrenal insufficiency: Excluding congenital adrenal hyperplasia


Author(s): Hasenmajer V, Ferrigno R, Minnetti M, Pellegrini B, Isidori AM, Lenzi A, Salerno M, Cappa M, Chan L, De Martino MC, Savage MO
Affiliated Institution / ERN:
Condition / Disease: genetic paediatric adrenal insufficiency
Publication: Reviews in Endocrine and Metabolic Disorders v24.2 p345-363 Year: 2023 ORPHAcode / other: ORPHA101958;ORPHA101959; ORPHA101960; ORPHA418; ORPHA869;
DOI: 10.1007/s11154-023-09784-7 Keywords: Addison,Adrenal insufficiency,Adrenoleukodystrophy,Aldosteron,Aldosterone Synthase,Allgrove syndrome,Cortisol,Familial glucocorticoid deficiency,Intrauterine growth retardation syndromes,Pseudohypoaldosteronism,Steroidogenesis,Triple A syndrome
MTG1
Page 10 of 30« First«...89101112...2030...»Last »

Endo-ERN Newsletter

Subscribe to our newsletter to receive updates on all network activities and new resources. As soon as you subscribe you will receive an email asking you to confirm your registration.

SIGN UP NOW

News

  • All news
  • Newsletter signup

Events

  • Upcoming events
  • Webinars

Information

  • About Us
  • Contact
  • FAQs

Social Links

Linkedin Facebook Youtube

Contact

Endo-ERN
Coordinating Center
Meibergdreef 9
1105 AZ AMSTERDAM
The Netherlands

info@endo-ern.eu
Funded by the European Union
©2025. All Rights Reserved. Endo-ERN

Privacy Policy – GDPR

Website design by Elan Creative

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Information video for patients and healthcare professionals

Type and Press “enter” to Search

Search
Privacy Overview
Endo-ERN

Endo-ERN Privacy Policy

Endo-ERN is committed to user’s privacy and does not track personal data when visiting our website. We act in accordance with Regulation 2016/679 of the European Parliament and of the Council.

‘Personal data’ means any information relating to an identified or identifiable natural person. An identifiable natural person is one who can be identified, directly or indirectly, in particular by reference to an identifier such as:

  • a name
  • an identification number
  • location data
  • an online identifier or to one or more factors specific to the physical, physiological, genetic, mental, economic, cultural or social identity of that natural person

Cookies

Endo-ERN only tracks anonymised data for statistical purposes. We do this via analytical cookies, placed through an anonymous IP Google analytics tag. The purpose of these cookies are to track the efficiency and success of the website.

These cookies do not store any personal data that can be linked to a natural person, but may save data such as inter alia, data about the website from which a person has come (the so-called referrer), which sub-pages were visited, or how often and for what duration a sub-page was viewed. The data collected through this is general data only, and cannot be traced back to one person.

It is possible to prevent the setting of cookies, by means of a setting of the Internet browser used. On top of that, already set cookies may be deleted at any time via an Internet browser or other software programs. This is possible in all popular Internet browsers.

Google Analytics does not share any data with third parties.

The principles of data protection do not apply to anonymous information and because these cookies minimally impact the privacy of the user, it is not necessary to ask for permission to use these cookies.

Newsletter

You may always unsubscribe from our newsletter at any time through the unsubscribe button located in our newsletter. Endo-ERN is both the controller and responsible for processing of any data regarding the newsletter. Endo-ERN does not make use of a third party for the Newsletter service.

E-services

Endo-ERN has a contact form, which activates your email software and allows you to send a comment or question to a general email address. When you send such a message, your personal data is collected only to the extent necessary to reply. If the team responsible for the mailbox is unable to answer your question, or your questions has regards to another party, it might forward your email to another service.

If you have any questions about the processing of your email and related personal data, do not hesitate to include them in your message.

The collected personal data and all information related to the above mentioned consultation is stored on the email server of the Endo-ERN Coordinating office and potentially those who have been concerned in the correspondence in order to respond to your comment.

Newsletter Tracking

The Endo-ERN newsletter makes use of tracking in order to be able to conduct a statistical analysis of the success or failure of online marketing campaigns. Endo-ERN may see if an email containing a newsletter was opened by a user, when it was opened, and which links were opened. 
The data collected through this tracking is generated and stored by Endo-ERN and is not shared with third parties, but may be used to adapt future content of newsletters in order to better meet the interests of our subscribers.

Contact details

For any questions regarding our privacy policy, please contact the Endo-ERN coordinating office.

You have the right to be forgotten and removed completely from the Endo-ERN contact database. To request this, please contact the Endo-ERN coordinating office.

Endo-ERN Coordinating Center, Meibergdreef 9, 1105 AZ  AMSTERDAM. The Netherlands

 info@endo-ern.eu
Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Powered by  GDPR Cookie Compliance